#United States #Healthcare Conference #J.P. Morgan #Amgen #Thousand Oaks

Amgen's Upcoming Presentation at the 2026 J.P. Morgan Healthcare Conference

Amgen, a prominent player in the biotechnology sector, is set to make a vital presentation at the 2026 J.P. Morgan Healthcare Conference. Scheduled for January 12, 2026, at 3:45 PM PT, the event will feature a keynote address from Robert A. Bradway, the company’s chairman and CEO. This conference, which is known for attracting major stakeholders in the healthcare industry, offers a platform for Amgen to highlight its latest advancements and strategic directions.

For individuals unable to attend the conference in person, Amgen will provide a live webcast of the presentation. This webcast will be accessible to media representatives, investors, and the public via Amgen’s official website at www.amgen.com, where they can also find details regarding the event iteratively updated. The recording will remain archived and available for review for at least 90 days following the conference. This access underscores Amgen's commitment to transparency and engagement with its stakeholders.

Amgen’s Innovation Commitment

Amgen has long been at the forefront of biopharmaceutical discoveries, emphasizing a mission to develop innovative treatments aimed at combatting some of the most challenging diseases worldwide. For over four decades, the company has played a pivotal role in establishing the biotechnology industry and continues to leverage cutting-edge technology combined with human genetic insights. This strategic focus allows Amgen to expand its pipeline of medicines that target serious conditions such as cancer, heart disease, osteoporosis, and various rare diseases.

The 2024 accolades the company received, including being named one of the "World's Most Innovative Companies" by Fast Company and one of Forbes'